BioTherapeutics | 1800 Kraft Dr., Suite 200, Blacksburg, VA, 24060


Disruptive precision medicine technology conquering inflammation and diabetes

Synthetic IBD Patients

Synthetic patient cohorts are key components in the design of in silico clinical trials. A virtual population group ideally reflects the individual diversity and variability plus characteristics that represent a clinical cohort population. The virtual population can be extremely useful in identifying the broad range of responses which are otherwise hard to predict in a clinical trial.

The drug development and approval process

A larger synthetic population of patient avatars was generated based on an expert guided random variation from the typical cases of IBD patients undergoing treatments of placebo, GED-0301, Anti-TNF-alpha, and BT-11.

Back to top